Total Debt
$7.4M
Net Debt
-$64.4M
Lexeo Therapeutics, Inc. Common Stock currently has $7.4M in total debt. Net debt is -$64.4M after cash offsets. This 'Net Cash' position indicates exceptional financial strength.
Financial Fundamentals
LXEO • Quarterly Data • 5Y View
| Date | Total Debt ($B) | Cash & Inv. ($B) | Net Debt ($B) | Total Assets | Debt/Assets |
|---|---|---|---|---|---|
| 2026-03-31 | 0.01 | 0.07 | -0.06Net Cash | 0.25 | 2.9% |
| 2025-12-31 | 0.01 | 0.18 | -0.17Net Cash | 0.27 | 2.9% |
| 2025-09-30 | 0.01 | 0.04 | -0.03Net Cash | 0.14 | 5.9% |
| 2025-06-30 | 0.01 | 0.13 | -0.12Net Cash | 0.18 | 5.1% |
| 2025-03-31 | 0.01 | 0.10 | -0.09Net Cash | 0.13 | 7.5% |
| 2024-12-31 | 0.01 | 0.12 | -0.11Net Cash | 0.15 | 6.8% |
| 2024-09-30 | 0.01 | 0.16 | -0.15Net Cash | 0.17 | 6.0% |
| 2024-06-30 | 0.01 | 0.17 | -0.16Net Cash | 0.19 | 5.7% |
| 2024-03-31 | 0.01 | 0.20 | -0.18Net Cash | 0.21 | 5.3% |
| 2023-12-31 | 0.01 | 0.12 | -0.11Net Cash | 0.14 | 8.3% |
| 2023-09-30 | 0.02 | 0.04 | -0.02Net Cash | 0.05 | 29.6% |
| 2023-06-30 | 0.01 | 0.05 | -0.03Net Cash | 0.06 | 19.5% |
| 2023-03-31 | 0.01 | 0.06 | -0.05Net Cash | 0.08 | 16.7% |
| 2022-12-31 | 0.01 | 0.08 | -0.06Net Cash | 0.10 | 13.9% |